Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets: Reply

Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets: Reply Review of Industrial Organization (2006) 28:189–193 © Springer 2006 DOI 10.1007/s11151-006-0003-y Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets: Reply 1, 2 YING KONG and JAMES R. SELDON School of Analytic Studies and Information Technology, York University, Toronto, Ontario, Canada M3J 1P3. Author for correspondence: E-mail: ykong@yorku.ca; Department of Economics, Thompson Rivers University, Kamloops, BC, Canada V2C5N3 We thank Vasco Rodrigues for his comments on “Pseudo-Generic Prod- ucts and Barriers to Entry in Pharmaceutical Markets” (Kong and Seldon, 2004, hereafter Barriers). That paper was aimed at discovering whether “under plausible demand and cost conditions, brand-name incumbents [could] find it profitable to produce pseudo-generics as a means of blocking rivals’ entry ... .” Our answer was in the affirmative; that possibility does exist. Rodrigues (2005) shifts the discussion somewhat by adducing specific parameter values over which our outcomes would not hold and challenges us to sharpen the wording of our propositions. He thus has helped make clear an ever-present danger in using specific examples to elaborate general conclusions. Much remains to be done before the model can be used to derive necessary principles, let alone to assist in judging whether real-world firms deliberately supply pseudo-generics for entry deterrence. We http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Review of Industrial Organization Springer Journals

Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets: Reply

Loading next page...
 
/lp/springer_journal/pseudo-generic-products-and-barriers-to-entry-in-pharmaceutical-yKyETl8jAQ
Publisher
Kluwer Academic Publishers
Copyright
Copyright © 2006 by Springer
Subject
Economics; Industrial Organization; Microeconomics
ISSN
0889-938X
eISSN
1573-7160
D.O.I.
10.1007/s11151-006-0003-y
Publisher site
See Article on Publisher Site

Abstract

Review of Industrial Organization (2006) 28:189–193 © Springer 2006 DOI 10.1007/s11151-006-0003-y Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets: Reply 1, 2 YING KONG and JAMES R. SELDON School of Analytic Studies and Information Technology, York University, Toronto, Ontario, Canada M3J 1P3. Author for correspondence: E-mail: ykong@yorku.ca; Department of Economics, Thompson Rivers University, Kamloops, BC, Canada V2C5N3 We thank Vasco Rodrigues for his comments on “Pseudo-Generic Prod- ucts and Barriers to Entry in Pharmaceutical Markets” (Kong and Seldon, 2004, hereafter Barriers). That paper was aimed at discovering whether “under plausible demand and cost conditions, brand-name incumbents [could] find it profitable to produce pseudo-generics as a means of blocking rivals’ entry ... .” Our answer was in the affirmative; that possibility does exist. Rodrigues (2005) shifts the discussion somewhat by adducing specific parameter values over which our outcomes would not hold and challenges us to sharpen the wording of our propositions. He thus has helped make clear an ever-present danger in using specific examples to elaborate general conclusions. Much remains to be done before the model can be used to derive necessary principles, let alone to assist in judging whether real-world firms deliberately supply pseudo-generics for entry deterrence. We

Journal

Review of Industrial OrganizationSpringer Journals

Published: Jan 12, 2006

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off